Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Peer Review reports

From: Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy for locally advanced rectal cancer: 3-year survival from a phase 2 study

Original Submission
20 Aug 2024 Submitted Original manuscript
23 Nov 2024 Reviewed Reviewer Report
6 Jan 2025 Reviewed Reviewer Report - Ali Shamseddine
19 Jan 2025 Reviewed Reviewer Report - Joseph Sgouros
28 Feb 2025 Author responded Author comments - Tao Zhang
13 Mar 2025 Reviewed Reviewer Report - Ali Shamseddine
16 Mar 2025 Reviewed Reviewer Report - Joseph Sgouros
11 Apr 2025 Author responded Author comments - Tao Zhang
Resubmission - Version 2
28 Feb 2025 Submitted Manuscript version 2
Publishing
24 Apr 2025 Editorially accepted
9 May 2025 Article published 10.1186/s12916-025-04087-x

You can find further information about peer review here.

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us